查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1571960

全球心臟義肢假體市場

Cardiac Prosthetic Devices
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 93 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球心臟義肢假體市場將達到 119 億美元

2023年全球心臟義肢假體市場估計為74億美元，預計2030年將達到119億美元，2023-2030年分析期間複合年成長率為7.2%。植入式心律調節器是本報告分析的細分市場之一，預計複合年成長率為 7.7%，到分析期結束時將達到 47 億美元。分析期間，體外心律調節器市場的複合年成長率預計為 6.8%。

美國市場預估成長19億美元，中國複合年成長率10.7%

到 2023 年，美國心臟義肢假體市場預計將達到 19 億美元。中國作為全球第二大經濟體，預計2030年市場規模將達29億美元，2023-2030年分析期間複合年成長率為10.7%。其他值得注意的區域市場包括日本和加拿大，在分析期間預計複合年成長率分別為 3.5% 和 6.4%。在歐洲，德國的複合年成長率預計為 4.3%。

全球心臟義肢假體市場－主要趨勢與促進因素總結

什麼是心臟義肢假體？

心臟義肢假體是用於支持或替換心臟受損或失效部件的醫療植入，為患有各種心臟疾病的患者提供挽救生命的解決方案。這些設備，包括心臟瓣膜、心律調節器、心臟去顫器和輔助人工心臟(VAD)，在結構性心臟病、心律不整和心臟衰竭的治療中發揮至關重要的作用。隨著全球心血管疾病（CVD）盛行率的不斷增加，特別是心臟瓣膜疾病和心臟衰竭，心臟義肢假體在現代心臟病學中變得至關重要。

心臟瓣膜置換術是最常進行的心臟義肢假體手術之一。透過用機械或生物瓣膜替換有缺陷的瓣膜來解決瓣膜狹窄和反流等問題。心律調節器和植入式心臟整流去顫器(ICD) 等設備有助於管理異常心律，輔助人工心臟可支持等待心臟移植的患者或患有晚期心臟衰竭的患者的心臟功能。心血管疾病仍然是全世界死亡的主要原因，因此心臟義肢假體對於改善受影響患者的生活品質和生存至關重要。

科技進步如何形塑心臟義肢假體市場？

技術進步透過提高設備性能、患者治療效果和手術成功率正在徹底改變心臟義肢假體市場。材料科學的創新促進了更耐用和生物相容性心臟瓣膜的開發。例如，新型機械瓣膜的設計具有更長的使用壽命，從而減少了翻修手術的需要。另一方面，生物瓣膜通常源自於動物組織，不需要長期使用血液稀釋劑，凝血風險較低。此外，經導管心臟瓣膜置換術，例如經導管主動脈瓣置換術（TAVR），正在獲得巨大的關注。 TAVR 是一種微創手術，無需進行心臟直視手術即可進行瓣膜置換術，從而減少恢復時間和相關風險。無導線心律調節器較小，更容易植入，因此感染疾病和其他併發症的風險較小。同樣，下一代 ICD 將具有增強的編程功能，以更好地檢測和治療危及生命的心律不整，從而改善患者的治療結果。此外，輔助人工心臟的進步使得這些裝置更小、更可靠且更容易在晚期心臟衰竭患者中進行管理。遠端監控和無線連接等數位健康技術的整合可實現即時病患監測、設備併發症的早期檢測以及更好的植入後護理，從而進一步推動心臟義肢假體市場的發展。

哪些患者和醫療保健趨勢正在推動心臟義肢假體的需求？

一些醫療保健和患者趨勢正在推動心臟義肢假體需求的成長。這是因為老年人更容易罹患心血管疾病，尤其是瓣膜性心臟病和心臟衰竭。隨著預期壽命的不斷延長，對心臟瓣膜置換術、心律調節器和其他心臟裝置的需求也不斷增加。此外，被診斷為先天性心臟疾病或早發性心血管疾病的年輕患者也受益於提供長期解決方案的義肢裝置的進步，而這些裝置適用於各種年齡層的患者，這對於患者來說變得極為重要。

另一個重要趨勢是人們越來越偏好微創手術。患者擴大尋求恢復更快、併發症更少、住院時間更短的治療方法。 TAVR、經導管二尖瓣瓣環成形(TMVR) 和微創心律調節器植入等技術正在滿足這一需求，使更多患者能夠接受挽救生命的手術，而無需承擔與心臟直視手術相關的風險。隨著這些手術變得越來越廣泛，心臟義肢假體也變得越來越容易被更多人所接受。

此外，對以患者為中心的護理的日益關注以及數位醫療的興起正在影響需求。患者和醫療保健提供者現在可以使用允許遠端監控的設備，從而實現更好的術後追蹤和個人化護理。這些進步將進一步推動對心臟義肢假體的需求，以改善慢性病管理、減少再入院率並提高患者滿意度。

心臟義肢假體市場的成長受到多種因素的推動。

心臟義肢假體市場的成長受到多種因素的推動，包括心血管疾病盛行率的上升、人口老化的加劇以及醫療技術的進步。主要因素之一是心臟瓣膜疾病和心律不整的發生率增加，尤其是老年人。隨著瓣膜性心臟病隨著老齡化的成長而變得越來越常見，對機械和生物人工心臟瓣膜的需求也不斷增加。 TAVR 等微創手術因其風險低、恢復時間快而越來越受歡迎，為市場擴張做出了巨大貢獻。

技術進步也是推動成長的重要因素。無導線心律調節器、可擴展 ICD 和微型輔助人工心臟等創新正在改善患者的治療效果並擴大適合治療的患者範圍。將心臟義肢假體與數位健康工具整合的能力可以對慢性心血管疾病患者進行即時監測和更好的管理，使這些設備對患者和醫療保健提供者都更加有效。

此外，對預防性醫療保健和早期診斷的日益關注導致擴大採用心臟義肢假體作為綜合心血管護理策略的一部分。新興市場醫療保健基礎設施的擴張，加上人們對心臟健康意識的增強，也為市場創造了新的機會。隨著世界各地的醫療保健系統努力應對日益增加的心血管疾病負擔，對先進、耐用和患者友好的心臟義肢假體的需求預計將繼續成長。

受訪企業範例（共42例）

  • Abbott Laboratories
  • Abiomed, Inc.
  • AtriCure, Inc.
  • Biotronik
  • Boston Scientific Corporation
  • Braile Biomedica
  • CryoLife, Inc.
  • Edwards Lifesciences Corporation
  • Labcor Laboratrios
  • Lepu Medical Technology Co,. Ltd.
  • Lifetech Scientific
  • LivaNova
  • Medtronic plc.
  • Meril Life Sciences Pvt. Ltd.
  • MicroPort Scientific
  • Shree Pacetronix
  • Siemens Healthcare GmbH
  • Sorin Group
  • St. Jude Medical, Inc.
  • TTK Healthcare
  • Venus Medtech
  • Vitatron

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 比賽

簡介目錄
Product Code: MCP21436

Global Cardiac Prosthetic Devices Market to Reach US$11.9 Billion by 2030

The global market for Cardiac Prosthetic Devices estimated at US$7.4 Billion in the year 2023, is expected to reach US$11.9 Billion by 2030, growing at a CAGR of 7.2% over the analysis period 2023-2030. Implantable Pacemakers, one of the segments analyzed in the report, is expected to record a 7.7% CAGR and reach US$4.7 Billion by the end of the analysis period. Growth in the External Pacemakers segment is estimated at 6.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.9 Billion While China is Forecast to Grow at 10.7% CAGR

The Cardiac Prosthetic Devices market in the U.S. is estimated at US$1.9 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$2.9 Billion by the year 2030 trailing a CAGR of 10.7% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.5% and 6.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.3% CAGR.

Global Cardiac Prosthetic Devices Market – Key Trends & Drivers Summarized

What Are Cardiac Prosthetic Devices, and Why Are They Crucial for Cardiac Care?

Cardiac prosthetic devices are medical implants used to support or replace damaged or failing components of the heart, offering life-saving solutions for patients with various heart conditions. These devices include heart valves, pacemakers, defibrillators, and ventricular assist devices (VADs), which play a pivotal role in managing structural heart diseases, arrhythmias, and heart failure. With the rising global incidence of cardiovascular diseases (CVDs), especially heart valve disorders and heart failure, cardiac prosthetic devices have become critical in modern cardiology.

Heart valve replacements are among the most commonly used cardiac prosthetic devices. They address issues like valve stenosis or regurgitation by replacing faulty valves with mechanical or biological alternatives. Devices like pacemakers and implantable cardioverter defibrillators (ICDs) help manage abnormal heart rhythms, while VADs are used to support heart function in patients awaiting heart transplants or for those with advanced heart failure. As cardiovascular disease remains the leading cause of death worldwide, cardiac prosthetic devices are essential for improving the quality of life and survival rates of affected patients.

How Are Technological Advancements Shaping the Cardiac Prosthetic Devices Market?

Technological advancements are revolutionizing the cardiac prosthetic devices market by improving device performance, patient outcomes, and procedural success rates. Innovations in materials science have led to the development of more durable and biocompatible heart valves. For instance, newer mechanical valves are designed to last a lifetime, reducing the need for repeat surgeries, while biological valves, often derived from animal tissue, offer a lower risk of clotting without requiring long-term blood thinners. Additionally, transcatheter heart valve replacement technologies, such as transcatheter aortic valve replacement (TAVR), have gained significant traction. TAVR is a minimally invasive procedure that allows valve replacement without the need for open-heart surgery, reducing recovery time and associated risks. Leadless pacemakers, which are smaller and easier to implant, offer less risk of infection and other complications. Similarly, next-generation ICDs come with enhanced programming to better detect and treat life-threatening arrhythmias, improving patient outcomes. Furthermore, advancements in VADs are making these devices more compact, reliable, and easier to manage for patients with advanced heart failure. The integration of digital health technologies, such as remote monitoring and wireless connectivity, is enabling real-time patient monitoring, early detection of device complications, and better post-implant care, further advancing the cardiac prosthetic devices market.

What Patient and Healthcare Trends Are Driving the Demand for Cardiac Prosthetic Devices?

Several healthcare and patient trends are driving the growing demand for cardiac prosthetic devices. The aging global population is one of the primary factors, as older individuals are more susceptible to cardiovascular diseases, particularly valvular heart diseases and heart failure. As life expectancy continues to rise, the need for heart valve replacements, pacemakers, and other cardiac devices is also increasing. Additionally, younger patients diagnosed with congenital heart defects or early-onset cardiovascular conditions are benefiting from advancements in prosthetic devices that offer long-term solutions, making these devices crucial for patients across various age groups.

Another significant trend is the rising preference for minimally invasive procedures. Patients are increasingly seeking treatments that offer quicker recovery times, fewer complications, and shorter hospital stays. Technologies like TAVR, transcatheter mitral valve repair (TMVR), and minimally invasive pacemaker implantation cater to this demand, enabling more patients to undergo life-saving procedures without the risks associated with open-heart surgery. The expanding availability of these procedures in more regions is making cardiac prosthetic devices accessible to a broader population.

Moreover, the growing focus on patient-centric care and the rise of digital health are influencing demand. Patients and healthcare providers now have access to devices that allow for remote monitoring, enabling better post-procedure follow-up and personalized care. These advancements improve the management of chronic conditions, reduce hospital readmissions, and enhance patient satisfaction, further driving demand for cardiac prosthetic devices.

Growth in the Cardiac Prosthetic Devices Market Is Driven by Several Factors

Growth in the cardiac prosthetic devices market is driven by several factors, including the rising prevalence of cardiovascular diseases, the growing aging population, and advancements in medical technologies. One of the key drivers is the increasing incidence of heart valve disorders and arrhythmias, particularly among older adults. As heart valve disease becomes more common with age, the demand for prosthetic heart valves, both mechanical and biological, is rising. Minimally invasive procedures like TAVR are gaining popularity due to their lower risks and faster recovery times, contributing significantly to market expansion.

Technological advancements are another crucial factor driving growth. Innovations such as leadless pacemakers, enhanced ICDs, and compact VADs are improving patient outcomes and expanding the range of patients eligible for treatment. The ability to integrate cardiac prosthetic devices with digital health tools is enabling real-time monitoring and better management of patients with chronic cardiovascular conditions, making these devices more effective and appealing to both patients and healthcare providers.

Additionally, the growing focus on preventive healthcare and early diagnosis is increasing the adoption of cardiac prosthetic devices as part of comprehensive cardiovascular care strategies. The expansion of healthcare infrastructure in developing regions, coupled with increased awareness about heart health, is also creating new opportunities for the market. As healthcare systems worldwide work to address the growing burden of cardiovascular diseases, the demand for advanced, durable, and patient-friendly cardiac prosthetic devices is expected to continue its upward trajectory.

Select Competitors (Total 42 Featured) -

  • Abbott Laboratories
  • Abiomed, Inc.
  • AtriCure, Inc.
  • Biotronik
  • Boston Scientific Corporation
  • Braile Biomedica
  • CryoLife, Inc.
  • Edwards Lifesciences Corporation
  • Labcor Laboratrios
  • Lepu Medical Technology Co,. Ltd.
  • Lifetech Scientific
  • LivaNova
  • Medtronic plc.
  • Meril Life Sciences Pvt. Ltd.
  • MicroPort Scientific
  • Shree Pacetronix
  • Siemens Healthcare GmbH
  • Sorin Group
  • St. Jude Medical, Inc.
  • TTK Healthcare
  • Venus Medtech
  • Vitatron

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Cardiac Prosthetic Devices - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Advances in Material Science and Biocompatibility Enhance the Development of Cardiac Prosthetic Devices
    • Rising Global Prevalence of Heart Diseases Propels the Demand for Cardiac Prosthetics
    • Technological Innovations in Prosthetic Valves Improve Durability and Functional Outcomes
    • Increasing Adoption of Minimally Invasive Procedures Boosts Market Growth for Cardiac Prosthetics
    • Growth in Geriatric Population Worldwide Drives the Need for Advanced Cardiac Prosthetic Solutions
    • Expansion of Healthcare Infrastructure in Emerging Markets Opens New Opportunities for Cardiac Prosthetics
    • Patient-Specific Implants and Customization Using 3D Printing Technology Propel Market Innovations
    • Integration of Smart Sensors in Prosthetic Devices Enhances Post-Operative Monitoring and
    • Ethical and Legal Issues Surrounding the Use of Advanced Prosthetic Devices in Cardiology
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Cardiac Prosthetic Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Cardiac Prosthetic Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Implantable Pacemakers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Implantable Pacemakers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Implantable Pacemakers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for External Pacemakers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for External Pacemakers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for External Pacemakers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Cardiac Prosthetic Devices Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Transcatheter Heart Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Transcatheter Heart Valves by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Tissue Heart Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Tissue Heart Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Tissue Heart Valves by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Mechanical Heart Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Mechanical Heart Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Mechanical Heart Valves by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Cardiac Prosthetic Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 23: Canada Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: Canada Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: Canada 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • JAPAN
    • Cardiac Prosthetic Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 26: Japan Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Japan Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: Japan 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • CHINA
    • Cardiac Prosthetic Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 29: China Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: China Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: China 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • EUROPE
    • Cardiac Prosthetic Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 32: Europe Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 33: Europe Historic Review for Cardiac Prosthetic Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Europe 16-Year Perspective for Cardiac Prosthetic Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 35: Europe Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Europe Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Europe 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • FRANCE
    • Cardiac Prosthetic Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 38: France Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: France Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: France 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • GERMANY
    • Cardiac Prosthetic Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 41: Germany Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Germany Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Germany 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 44: Italy Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Italy Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Italy 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Cardiac Prosthetic Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 47: UK Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: UK Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: UK 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 50: Spain Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Spain Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Spain 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 53: Russia Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Russia Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Russia 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 56: Rest of Europe Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Rest of Europe Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Rest of Europe 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Cardiac Prosthetic Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 59: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 60: Asia-Pacific Historic Review for Cardiac Prosthetic Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Asia-Pacific 16-Year Perspective for Cardiac Prosthetic Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 62: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Asia-Pacific Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Asia-Pacific 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Cardiac Prosthetic Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 65: Australia Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Australia Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Australia 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • INDIA
    • Cardiac Prosthetic Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 68: India Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: India Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: India 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 71: South Korea Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: South Korea Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: South Korea 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 74: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Rest of Asia-Pacific Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Rest of Asia-Pacific 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Cardiac Prosthetic Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 77: Latin America Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 78: Latin America Historic Review for Cardiac Prosthetic Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Latin America 16-Year Perspective for Cardiac Prosthetic Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 80: Latin America Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Latin America Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Latin America 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 83: Argentina Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Argentina Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Argentina 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 86: Brazil Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Brazil Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Brazil 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 89: Mexico Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Mexico Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Mexico 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 92: Rest of Latin America Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Latin America Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of Latin America 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Cardiac Prosthetic Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 95: Middle East Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 96: Middle East Historic Review for Cardiac Prosthetic Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Middle East 16-Year Perspective for Cardiac Prosthetic Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 98: Middle East Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Middle East Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Middle East 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 101: Iran Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Iran Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Iran 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 104: Israel Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Israel Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Israel 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 107: Saudi Arabia Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Saudi Arabia Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Saudi Arabia 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 110: UAE Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: UAE Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: UAE 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 113: Rest of Middle East Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Rest of Middle East Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: Rest of Middle East 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030
  • AFRICA
    • Cardiac Prosthetic Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 116: Africa Recent Past, Current & Future Analysis for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Africa Historic Review for Cardiac Prosthetic Devices by Product - Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: Africa 16-Year Perspective for Cardiac Prosthetic Devices by Product - Percentage Breakdown of Value Sales for Implantable Pacemakers, External Pacemakers, Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2014, 2024 & 2030

IV. COMPETITION